cetirizine has been researched along with Airway Hyper-Responsiveness in 10 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study shows that cetirizine treatment reduces cough intensity (P < 0." | 6.68 | Cetirizine treatment of allergic cough in children with pollen allergy. ( Canonica, GW; Ciprandi, G; Fasce, L; Fregonese, L; Passalacqua, G; Ricca, V; Tosca, M, 1997) |
| "The pharmacokinetic/pharmacodynamic profile of levocetirizine was studied in 15 toddlers suffering from recurrent cough and other allergy-related symptoms, aged 20." | 5.11 | Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile. ( Cranswick, N; Fuchs, M; Hulhoven, R; Turzíkova, J, 2005) |
| "Sixteen atopic patients with mild-to-moderate asthma of whom 10 were receiving inhaled corticosteroid therapy (all had positive results to house dust mite on skin prick testing) were randomized in a double-blind, placebo-controlled, cross-over fashion to receive single doses of 5 mg of desloratadine, 180 mg of fexofenadine hydrochloride (FEX), 5 mg of levocetirizine dihydrochloride (LEV), or placebo, with AMP challenge performed 12 hours after dosing." | 5.10 | Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma. ( Bates, CE; Currie, GP; Lee, DK; Lipworth, BJ, 2003) |
| "Using human eosinophils isolated from patients with allergic rhinitis, the cells were cultured in vitro for 48 to 72 hours with medium, cetirizine, or dexamethasone in the presence of IL-5, IL-3, or GM-CSF." | 3.69 | Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival. ( Busse, WW; Sedgwick, JB, 1997) |
| "This study shows that cetirizine treatment reduces cough intensity (P < 0." | 2.68 | Cetirizine treatment of allergic cough in children with pollen allergy. ( Canonica, GW; Ciprandi, G; Fasce, L; Fregonese, L; Passalacqua, G; Ricca, V; Tosca, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, DK | 1 |
| Bates, CE | 1 |
| Currie, GP | 1 |
| Lipworth, BJ | 1 |
| Magnan, A | 1 |
| Cranswick, N | 1 |
| Turzíkova, J | 1 |
| Fuchs, M | 1 |
| Hulhoven, R | 1 |
| Rihoux, JP | 1 |
| Mariz, S | 1 |
| Sedgwick, JB | 1 |
| Busse, WW | 1 |
| Ciprandi, G | 1 |
| Tosca, M | 1 |
| Ricca, V | 1 |
| Passalacqua, G | 1 |
| Fregonese, L | 1 |
| Fasce, L | 1 |
| Canonica, GW | 2 |
| Bertrand, B | 1 |
| Eloy, P | 1 |
| Rombeaux, P | 1 |
| Riemann, R | 1 |
| Riemann, E | 1 |
| Milewski, C | 1 |
| Togias, AG | 1 |
| Proud, D | 1 |
| Kagey-Sobotka, A | 1 |
| Freidhoff, L | 1 |
| Lichtenstein, LM | 1 |
| Naclerio, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy and Safety of Levocetirizine Dihydrochloride Oral Drops Given 0.125 mg/kg b.i.d. During 90 Days in the Treatment of Recurrent Cough Associated With Other Allergic Symptoms, e.g. Wheezing, in Children Aged 1-2 Years.[NCT00520754] | Phase 2 | 15 participants (Actual) | Interventional | 2001-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for cetirizine and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy.
Topics: Animals; Cetirizine; Humans; Hypersensitivity, Immediate; Insect Bites and Stings; Respiratory Hyper | 1993 |
Adhesion molecules and H1-antihistamines.
Topics: Cell Adhesion Molecules; Cetirizine; Histamine H1 Antagonists; Humans; Respiratory Hypersensitivity | 1997 |
Allergy and sinusitis.
Topics: Allergens; Anti-Allergic Agents; Anti-Inflammatory Agents; Beclomethasone; Blood Proteins; Cetirizin | 1997 |
4 trials available for cetirizine and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma.
Topics: Acetates; Adenosine Monophosphate; Adult; Aged; Asthma; Bronchial Provocation Tests; Cetirizine; Cro | 2003 |
Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.
Topics: Age Factors; Cetirizine; Cough; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Male | 2005 |
Cetirizine treatment of allergic cough in children with pollen allergy.
Topics: Adolescent; Anti-Allergic Agents; Cetirizine; Child; Cough; Double-Blind Method; Female; Humans; Mal | 1997 |
In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease.
Topics: Administration, Intranasal; Administration, Oral; Administration, Topical; Adolescent; Adult; Benzhy | 1989 |
3 other studies available for cetirizine and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
[Respiratory allergies in the child and the adult].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Allergens; Anti-Allergic Ag | 2004 |
Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival.
Topics: Adult; Antibodies, Monoclonal; Cell Adhesion; Cell Survival; Cells, Cultured; Cetirizine; Chemotaxis | 1997 |
[Skin prick test results in snoring and sleep apnea patients].
Topics: Adolescent; Adult; Aged; Allergens; Cetirizine; Child; Female; Humans; Intradermal Tests; Male; Midd | 2002 |